1. Home
  2. BLLN vs AZZ Comparison

BLLN vs AZZ Comparison

Compare BLLN & AZZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BillionToOne Inc.

BLLN

BillionToOne Inc.

N/A

Current Price

$93.00

Market Cap

4.4B

Sector

Health Care

ML Signal

N/A

Logo AZZ Inc.

AZZ

AZZ Inc.

N/A

Current Price

$139.25

Market Cap

4.4B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
BLLN
AZZ
Founded
2016
1956
Country
United States
United States
Employees
713
N/A
Industry
Medical Specialities
Industrial Specialties
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
4.4B
4.4B
IPO Year
2025
1994

Fundamental Metrics

Financial Performance
Metric
BLLN
AZZ
Price
$93.00
$139.25
Analyst Decision
Buy
Buy
Analyst Count
7
5
Target Price
$126.71
$141.80
AVG Volume (30 Days)
797.8K
194.1K
Earning Date
05-06-2026
04-22-2026
Dividend Yield
N/A
0.58%
EPS Growth
103.40
486.59
EPS
0.48
1.72
Revenue
$305,112,000.00
$1,061,817,000.00
Revenue This Year
$46.29
$7.03
Revenue Next Year
$30.14
$4.25
P/E Ratio
$198.23
$81.24
Revenue Growth
99.97
14.53
52 Week Low
$61.96
$92.98
52 Week High
$150.44
$162.20

Technical Indicators

Market Signals
Indicator
BLLN
AZZ
Relative Strength Index (RSI) 39.93 37.90
Support Level $88.38 $138.66
Resistance Level $95.82 $141.50
Average True Range (ATR) 4.51 4.08
MACD 0.13 -1.07
Stochastic Oscillator 47.48 10.93

Price Performance

Historical Comparison
BLLN
AZZ

About BLLN BillionToOne Inc.

BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.

About AZZ AZZ Inc.

AZZ Inc is a provider of galvanizing and coil coating solutions to a broad range of end markets in North America. The company's operating segment consists of AZZ Metal Coatings, AZZ Precoat Metals, and AZZ Infrastructure Solutions. The company generates the majority of its revenue from the Precoat Metals segment, which provides coil coating application of protective and decorative coatings and related value-added downstream processing for steel and aluminum coils. Geographically, the company operates in the United States and Canada.

Share on Social Networks: